Intimation of Analyst Meet

Board & Shareholder Meetings View source PDF

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.8%1-day move

₹380.05

prior close

₹390.75

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1-0.1-0.5—+3.8+3.3+3.0-0.3+0.9-0.4-1.1-1.3+8.7—

Up moveDown movePending

AI summary

Aarti Drugs Ltd has disclosed a scheduled investor meeting for 27th May 2026 from 10:00 AM to 1:00 PM at Grand Hyatt, Mumbai. The meeting is a 1x1/group session organised by 360 ONE Capital (B&K). The company clarifies that discussions will be limited to publicly available information and that no Unpublished Price Sensitive Information (UPSI) will be shared. This is a routine regulatory filing under SEBI Listing Regulations, specifically Regulation 30(6), filed on 22nd May 2026.

Likely market impact

This is a standard compliance disclosure with no new material information. It indicates active investor engagement but carries no direct impact on the stock price or fundamentals.